“The credibility and recognized successful track record of Shavit opened to us new doors in the international public markets.”
Ehud Marom, Mapi Pharma, Chairman & CEO
Ehud Marom, Mapi Pharma, Chairman & CEO
Dov Tamarkin, Foamix Pharmaceuticals, Co-Founder & CEO
Shavit Capital is an investment practice that specializes in late-stage investments in Israeli and Israeli-related companies.
Shavit Capital, founded in 2008, has over $500 million under management across five separate private equity funds. The Funds invest in Israeli companies with proven technologies, products, markets and strong management teams. The Funds invest in equity mezzanine or bridge rounds in companies which subsequently expect to raise relatively larger amounts pursuant to an IPO on a major international public exchange or a dual listing of a company that trades on the Tel Aviv Stock Exchange.
Shavit Capital also invests in other late-stage opportunities, especially through PIPEs (Private Investment in Public Equity) of publicly-traded companies